Hogervorst E K, Rosseel P M J, van de Watering L M G, Brand A, Bentala M, van der Meer B J M, van der Bom J G
Centre for Clinical Transfusion Research, Sanquin Research, Leiden, The Netherlands.
Jon J van Rood Centre for Clinical Transfusion Research, Leiden University Medical Centre, Leiden, The Netherlands.
Neth Heart J. 2018 Nov;26(11):540-551. doi: 10.1007/s12471-018-1161-x.
The EuroSCORE I was one of the most frequently used pre-operative risk models in cardiac surgery. In 2011 it was replaced by its successor the EuroSCORE II. This study aims to validate the EuroSCORE II and to compare its performance with the EuroSCORE I in a Dutch hospital.
The EuroSCORE II was prospectively validated in 2,296 consecutive cardiac surgery patients between 1 April 2012 and 1 January 2014. Receiver operating characteristic curves on in-hospital mortality were plotted for EuroSCORE I and EuroSCORE II, and the area under the curve was calculated to assess discriminative power. Calibration was assessed by comparing observed versus expected mortality. Additionally, analyses were performed in which we stratified for type of surgery and for elective versus emergency surgery.
The observed mortality was 2.4% (55 patients). The discriminative power of the EuroSCORE II surpassed that of the EuroSCORE I (area under the curve EuroSCORE II 0.871, 95% confidence interval (CI) 0.832-0.911; area under the curve additive EuroSCORE I 0.840, CI 0.798-0.882; area under the curve logistic EuroSCORE I 0.761, CI 0.695-0.828). Both the additive and the logistic EuroSCORE I overestimated mortality (predictive mortality additive EuroSCORE I median 5.0%, inter-quartile range 3.0-8.0%; logistic EuroSCORE I 10.7%, inter-quartile range 5.8-13.9), while the EuroSCORE II underestimated mortality (median 1.6%, inter-quartile range 1.0-3.5). In most stratified analyses the EuroSCORE II performed better.
Our results show that the EuroSCORE II produces a valid risk prediction and outperforms the EuroSCORE I in elective cardiac surgery patients.
欧洲心脏手术风险评估系统I(EuroSCORE I)是心脏手术中最常用的术前风险模型之一。2011年,它被其继任者欧洲心脏手术风险评估系统II(EuroSCORE II)所取代。本研究旨在验证EuroSCORE II,并在一家荷兰医院将其与EuroSCORE I的性能进行比较。
2012年4月1日至2014年1月1日期间,对2296例连续接受心脏手术的患者进行了EuroSCORE II的前瞻性验证。绘制了EuroSCORE I和EuroSCORE II关于院内死亡率的受试者工作特征曲线,并计算曲线下面积以评估辨别力。通过比较观察到的死亡率与预期死亡率来评估校准情况。此外,我们还进行了按手术类型以及择期手术与急诊手术分层的分析。
观察到的死亡率为2.4%(55例患者)。EuroSCORE II的辨别力超过了EuroSCORE I(EuroSCORE II曲线下面积0.871,95%置信区间(CI)0.832 - 0.911;相加性EuroSCORE I曲线下面积0.840,CI 0.798 - 0.882;逻辑回归EuroSCORE I曲线下面积0.761,CI 0.695 - 0.828)。相加性和逻辑回归EuroSCORE I均高估了死亡率(相加性EuroSCORE I预测死亡率中位数5.0%,四分位间距3. -- 8.0%;逻辑回归EuroSCORE I 10.7%,四分位间距5.8 - 13.9),而EuroSCORE II低估了死亡率(中位数1.6%,四分位间距1.0 - 3.5)。在大多数分层分析中,EuroSCORE II表现更好。
我们的结果表明,EuroSCORE II能产生有效的风险预测,并且在择期心脏手术患者中其表现优于EuroSCORE I。